Search research articles
Contact Us
Filters
Showing results (91-100 of 129) with videos related to
Page
of 13
Sort By:
International Journal of Cancer
|
February 22, 2002
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells
Ulrike Stein, Hermann Lage, Andreas Jordan, et al.
Bioorganic & Medicinal Chemistry
|
December 4, 2012
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties
Christiane Baumert, Marianne Günthel, Sören Krawczyk, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 28, 2011
CD46 Expression is an unfavorable prognostic factor in breast cancer cases
Adam Maciejczyk, Jolanta Szelachowska, Bartłomiej Szynglarewicz, et al.
Virchows Archiv : an International Journal of Pathology
|
January 20, 2007
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome
Paweł Surowiak, Verena Materna, Adam Maciejczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome
Pawel Surowiak, Verena Materna, Irina Kaplenko, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 25, 2006
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates
Pawel Surowiak, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Human Gene Therapy
|
January 18, 2006
Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520
Alexa Bieler, Klaus Mantwill, Tanja Dravits, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
November 22, 2012
Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluation
Andreas Hilgeroth, Christiane Baumert, Claudius Coburger, et al.
Frontiers in Pharmacology
|
May 28, 2020
Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
Mariana Alves Reis, Ana M Matos, Noélia Duarte, et al.
Journal of Gastroenterology and Hepatology
|
July 25, 2007
Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes
Guido Schumacher, Janine Hoffmann, Thorsten Cramer, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 129) with videos related to
Sort By:
Page
of 13
International Journal of Cancer
|
February 22, 2002
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells
Ulrike Stein, Hermann Lage, Andreas Jordan, et al.
Bioorganic & Medicinal Chemistry
|
December 4, 2012
Development of small-molecule P-gp inhibitors of the N-benzyl 1,4-dihydropyridine type: novel aspects in SAR and bioanalytical evaluation of multidrug resistance (MDR) reversal properties
Christiane Baumert, Marianne Günthel, Sören Krawczyk, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 28, 2011
CD46 Expression is an unfavorable prognostic factor in breast cancer cases
Adam Maciejczyk, Jolanta Szelachowska, Bartłomiej Szynglarewicz, et al.
Virchows Archiv : an International Journal of Pathology
|
January 20, 2007
Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome
Paweł Surowiak, Verena Materna, Adam Maciejczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome
Pawel Surowiak, Verena Materna, Irina Kaplenko, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 25, 2006
Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates
Pawel Surowiak, Verena Materna, Malgorzata Drag-Zalesinska, et al.
Human Gene Therapy
|
January 18, 2006
Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520
Alexa Bieler, Klaus Mantwill, Tanja Dravits, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
November 22, 2012
Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluation
Andreas Hilgeroth, Christiane Baumert, Claudius Coburger, et al.
Frontiers in Pharmacology
|
May 28, 2020
Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
Mariana Alves Reis, Ana M Matos, Noélia Duarte, et al.
Journal of Gastroenterology and Hepatology
|
July 25, 2007
Antineoplastic activity of 2-methoxyestradiol in human pancreatic and gastric cancer cells with different multidrug-resistant phenotypes
Guido Schumacher, Janine Hoffmann, Thorsten Cramer, et al.
Page
of 13